Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-05-18 07:10 |
Pharming Group: Interim Report on Financial Results for Q1 2016
|
English | 777.1 KB | ||
| 2016-05-16 08:59 |
Pharming Group Supports hae day :-) 2016
|
English | 139.5 KB | ||
| 2016-04-07 15:54 |
Pharming Announces Adoption by the European Commission of the CHMP Recommendati…
|
English | 28.3 KB | ||
| 2016-03-24 16:09 | English | 5.1 MB | |||
| 2016-03-10 08:17 |
Pharming Group Report on Preliminary Financial Results 2015
|
English | 704.1 KB | ||
| 2016-02-29 08:49 |
Home Member State Declaration Pursuant to the Amended Article 5:25a Paragraph 2…
|
Dutch | 131.6 KB | ||
| 2016-02-26 15:55 |
Pharming Announces Positive CHMP Opinion to Change the Terms of the Marketing A…
|
English | 146.5 KB | ||
| 2016-02-09 08:14 |
Pharming and Cytobioteck Announce Extension of Distribution Agreement for RUCON…
|
English | 43.9 KB | ||
| 2016-01-06 07:19 |
Pharming Announces Completion of Patient Enrolment in Clinical Study of RUCONES…
|
English | 138.2 KB | ||
| 2015-12-21 08:42 |
Pharming and Hyupjin Announce Receipt of the South Korean Marketing Authorisati…
|
English | 134.9 KB | ||
| 2015-12-07 08:41 |
European Medicines Agency Reaffirms Important Health Benefits and Safety of RUC…
|
English | 87.3 KB | ||
| 2015-10-29 18:07 | English | 552.6 KB | |||
| 2015-10-28 07:04 |
Pharming Group NV Interim Report January - September 2015
|
English | 510.8 KB | ||
| 2015-10-08 08:34 |
FDA Grants RUCONEST® (C1 Esterase Inhibitor [Recombinant]) Twelve-Year Referenc…
|
English | 325.5 KB | ||
| 2015-09-08 08:40 |
Pharming Nominates Mr Robin Wright as Chief Financial Officer
|
English | 107.2 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
